MDNA

Medicenna Therapeutics Corp. Common Shares
MDNA

Overview Fund Activity
Delisted

MDNA was delisted on the 1st of November, 2023.

Back to rankings

28 hedge funds and large institutions have $8.11M invested in Medicenna Therapeutics Corp. Common Shares in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+9
Holders Change %
+47.37%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
10
Increased
8
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACM
AIGH Capital Management
Maryland
$3.19M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
$830K
3
DCM
DAFNA Capital Management
California
$548K
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
$539K
5
EAM
Empery Asset Management
New York
$489K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
$1K
2
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
$2K
3
Millennium Management
Millennium Management
New York
$10K
4
TRCT
Tower Research Capital (TRC)
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$1K -$111K -200,000 -99%
Bank of America
27
Bank of America
North Carolina
$1K +$1K +1,500 New
NDSI
28
Newman Dignan & Sheerar Inc
Rhode Island
$11 +$11 +12,915 New
TRCT
29
Tower Research Capital (TRC)
New York
– -$2K -1,464 Closed
1
2